VASO Stock | News | Quote | Stock Forum | Sunday, October 27,

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Vasomedical, Inc. VASO Company Overview 

Vasomedical, Inc. VASO Current Price and Quotes
Last Price 0.28
Previous Close 0.276 Open 0.2451
Daily Range 0.28 - 0.2451 52wk Range 0.37 - 0.10
Volume 30,156 Dividend N/A
Average Vol (3m) 211,217 Yield N/A

VASO Stock Message Board http://investorshangout.com/search?q=VASO&...mp;yt1=Go!

Last Updated: Sunday, October 27, 2013 02:15:50 AM

Vasomedical, Inc. VASO
Company Information

180 Linden Ave.
Westbury, NY 11590

Website: http://www.vasomedical.com
Phone: (516) 997-4600
Email: customerservice@vasomedical.com

Vasomedical, Inc. VASO
Vasomedical, Inc. VASO
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Jun 30, 2013 10-Q
CIK 0000839087
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 3845 - Electromedical equipment
Incorporated In: DE, USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts

Jun Ma President, CEO
Michael Beecher CFO
Jonathan P. Newton VP, Fin., Controller
Investor Relations IR
Company Directors

Peter C. Castle
Company Notes

Formerly=Future Medical Products, Inc until 5-95
Service Providers

Auditor/Accountant
Rothstein, Kass & Company, P.C.
2050 Main St.
Suite 200
Irvine, CA, 92614
United States

Legal Counsel
Not Available
Investor Relations Firm
Not Available

Vasomedical, Inc. VASO
VASO Security Details

Share Structure

Market Value1 $43,585,302 a/o Oct 25, 2013
Shares Outstanding 155,661,792 a/o Aug 09, 2013
Float Not Available
Authorized Shares Not Available
Par Value  0.001
Shareholders

Shareholders of Record 1,100 a/o Apr 30, 2012
Security Notes

New Issue=10-88 2,500,000 shs in units (5 shs Com & 3 Warr 10-23-90) at $5.10 per unit (best efforts-300,000 units or none) by the company
Note=5-26-06 deleted from NASDAQ
Short Selling Data

Short Interest 27,251 (91.07%)
Sep 30, 2013
Significant Failures to Deliver  No
Transfer Agent(s)

American Stock Transfer & Trust Company

Vasomedical, Inc. VASO Financials
Period Ending Dec 31, 2012 Dec 31, 2011 May 31, 2011 May 31, 2010
Total Revenue 29,240 23,489 16,373 4,206
Cost of Revenue 8,646 6,733 5,461 1,994
Gross Profit 20,594 16,756 10,912 2,212
Operating Expenses

Research and Development 576 324 462 419
Sales, General and Admin. 23,526 11,243 14,383 3,773
Non-Recurring Items - - - -
Other - - - -
Operating Income (3,508) 5,189 (3,933) (1,980)
Income From Continuing Operations

Add'l Income/Expense Items 181 208 81 133
Earnings Before Interest and Tax (3,327) 5,397 (3,852) (1,847)
Interest Expense 2 9 32 5
Earnings Before Tax (3,329) 5,388 (3,884) (1,852)
Income Tax 52 276 7 (36)
Minority Interest - - - 76
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (3,381) 5,112 (3,891) (1,892)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (3,381) 5,112 (3,891) (1,892)
Preferred Stock and Other Adjustments - (1,221) (429) -
Net Income Applicable to Common Shareholders (3,381) 3,891 (4,320) (1,892)

Vasomedical, Inc. VASO Recent News

Sep 9, 2013 EECP Therapy Receives Class lla Recommendation in European Society of Cardiology Guidelines for the Management of Stable Coronary Artery Disease
Aug 13, 2013 Vasomedical Announces Financial Results for the Second Quarter of 2013
Aug 9, 2013 Vasomedical Inc is Featured as the Daily Momentum Gainer to watch on Smallcappower.com
Aug 6, 2013 Vasomedical to Report Second Quarter 2013 Results on August 13, 2013


VASO Vasomedical, Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=VASO&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/VASO/quote
Stock Chart http://www.otcmarkets.com/stock/VASO/chart
Company Info http://www.otcmarkets.com/stock/VASO/company-info
Recent News http://www.otcmarkets.com/stock/VASO/news
Financials http://www.otcmarkets.com/stock/VASO/financials
Filings and Disclosure http://www.otcmarkets.com/stock/VASO/filings
Short Sales http://www.otcmarkets.com/stock/VASO/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/VASO/insider-transactions
Research Reports http://www.otcmarkets.com/stock/VASO/research
Summary http://finance.yahoo.com/q?s=VASO
Historical Prices http://finance.yahoo.com/q/hp?s=VASO+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=VASO
Basic Chart http://finance.yahoo.com/q/bc?s=VASO+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=VASO+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=VASO+Headlines
Press Releases http://finance.yahoo.com/q/p?s=VASO+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=VASO+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=VASO+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=VASO+Industry
Major Holders http://finance.yahoo.com/q/mh?s=VASO+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=VASO+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=VASO+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=VASO
Balance Sheet http://finance.yahoo.com/q/bs?s=VASO
Cash Flow http://finance.yahoo.com/q/cf?s=VASO+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/VASO
Market Watch http://www.marketwatch.com/investing/stock/VASO
Bloomberg http://www.bloomberg.com/quote/VASO:US
Morningstar http://quotes.morningstar.com/stock/s?t=VASO
Bussinessweek http://investing.businessweek.com/research/st...icker=VASO
Barchart http://www.barchart.com/quotes/stocks/VASO
OTC Short Report http://otcshortreport.com/index.php?index=VASO
Investopedia http://www.investopedia.com/markets/stocks/VASO/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Comprehensive Update on Voting Rights and Share Capital Status

Updated Category News Views 63

URW SE stirred the pot back in September when they updated their voting rights and share capital. With a hefty total of 139,370,486 shares, this company is a real heavyweight in the European market. Shareholders can flex some serious muscle when it comes to company decisions. It's not just about holding shares; it's about wielding influence where it counts. Voting Rights:...

Continue Reading
Veteran Realtor Kate Johnson Earns Inner Circle Honor

Updated Category News Views 10

Decades of Real Estate Mastery under Kate Johnson's Belt In a world where the real estate market twists and turns like a seasoned poker player, Kate Johnson stands tall as a beacon of consistency and trust. Over five decades—yes, you heard it right, more than 51 years—she's been slicing through the complexity of the residential real estate landscape like a hot knife...

Continue Reading
JPMorgan Supports Homeowners Affected by Wildfires

Updated Category News Views 164

JPMorgan Chase Assists Homeowners During Wildfire Crisis In response to the recent wildfires impacting many communities, JPMorgan Chase (NYSE: JPM) has stepped up to offer significant support to its mortgage customers. The bank's home lending unit has introduced a disaster forbearance program specifically designed to assist homeowners affected by these devastating events....

Continue Reading
Investigation Launched on Brookline Bancorp Sale to Berkshire

Updated Category News Views 205

Halper Sadeh LLC Investigates Brookline Bancorp's Sale In a significant move that has caught the attention of investors and financial experts alike, Halper Sadeh LLC has announced its investigation regarding the sale of Brookline Bancorp, Inc. (NASDAQ: BRKL) to Berkshire Hills Bancorp, Inc. This is regarding whether the terms of the sale—0.42 shares of Berkshire common...

Continue Reading
Investigating SARS-CoV-2: Understanding Orphan Genes Role

Updated Category News Views 217

Orphan Genes and COVID-19 Severity The recent discoveries related to orphan genes in the SARS-CoV-2 virus signify a promising avenue for advancing our understanding of COVID-19. Researchers from an international collaborative team have identified an orphan gene within the virus that plays a crucial role in determining the severity of COVID-19. This research could not only...

Continue Reading